SCREENING FRAX® in clinical practice

Assigning osteoporosis treatment on the basis of bone mineral density alone is difficult, and incorporating even simple clinical risk factors into the decision-making process is challenging. When launched, the FRAX (R) risk assessment tool was met, unsurprisingly, with both enthusiasm and skepticism; despite improvements, some obstacles still prevent its universal implementation.